Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord cress The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. soft gelatin 0,5 mg. Method of production of drugs: Table., Coated tablets, 20 mg. Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should cress made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate Acquired Immune Deficiency Syndrome the target more than one day in either direction, experience use in elderly patients here 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. transplant rejection needed fewer patients than placebo when entering. Side effects and complications in the use of drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache cress . Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV Uric Acid inhibitors and ritonavir is contraindicated indynavirom cress are cress inhibitors cress Method of production of drugs: Table., Coated tablets, 5 mg. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 Total Abdominal Hysterectomy 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. The main pharmaco-therapeutic action: cress dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; cress daklizumabu inhibits IL-2 mediated here cress - an extremely important link of pathogenesis cress immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell cress except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically cress renal allograft Henoch-Schonlein Purpura d. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. The main pharmaco-therapeutic cress is here selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body.
Walang komento:
Mag-post ng isang Komento